Recent advances in the development of legumain-selective chemical probes and peptide prodrugs
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in the development of legumain-selective chemical probes and peptide prodrugs
Authors
Keywords
-
Journal
BIOLOGICAL CHEMISTRY
Volume -, Issue -, Pages -
Publisher
Walter de Gruyter GmbH
Online
2019-04-25
DOI
10.1515/hsz-2019-0135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Legumain-Specific Near-Infrared Fluorescence “Turn On” for Tumor-Targeted Imaging
- (2018) Yue Zhao et al. ANALYTICAL CHEMISTRY
- Colchicine prodrugs and codrugs: Chemistry and bioactivities
- (2018) Abdullah A. Ghawanmeh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states
- (2018) Elfriede Dall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crystal Structure of Plant Legumain Reveals a Unique Two-Chain State with pH-Dependent Activity Regulation
- (2018) Florian B. Zauner et al. PLANT CELL
- Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells
- (2017) Hanna Wallin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity
- (2017) Marcin Poreba et al. Nature Protocols
- The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database
- (2017) Neil D Rawlings et al. NUCLEIC ACIDS RESEARCH
- Development of a smart activity-based probe to detect subcellular activity of asparaginyl endopeptidase in living cells
- (2017) Jong-Ah Hong et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Highly sensitive and adaptable fluorescence-quenched pair discloses the substrate specificity profiles in diverse protease families
- (2017) Marcin Poreba et al. Scientific Reports
- Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
- (2016) Giuseppa Pistritto et al. Aging-US
- Structure and function of legumain in health and disease
- (2016) Elfriede Dall et al. BIOCHIMIE
- Flat SAR of P3-methylsulphonamide based small molecule legumain inhibitors
- (2016) Kerry Anne Ness et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Intracellular Self-Assembly and Disassembly of 19F Nanoparticles Confer Respective “Off” and “On” 19F NMR/MRI Signals for Legumain Activity Detection in Zebrafish
- (2015) Yue Yuan et al. ACS Nano
- Structure and Mechanism of an Aspartimide-Dependent Peptide Ligase in Human Legumain
- (2015) Elfriede Dall et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Development of a potent and selective cell penetrant Legumain inhibitor
- (2015) Kerry A. Ness et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and Evaluation of a CBZ-AAN-Dox Prodrug and itsin vitroEffects on SiHa Cervical Cancer Cells Under Hypoxic Conditions
- (2015) Hongyuan Chen et al. Chemical Biology & Drug Design
- Small Molecule Active Site Directed Tools for Studying Human Caspases
- (2015) Marcin Poreba et al. CHEMICAL REVIEWS
- Peptide Macrocyclization by a Bifunctional Endoprotease
- (2015) Kalia Bernath-Levin et al. CHEMISTRY & BIOLOGY
- High expression of the cysteine proteinase legumain in colorectal cancer – Implications for therapeutic targeting
- (2015) Mads H. Haugen et al. EUROPEAN JOURNAL OF CANCER
- Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis
- (2015) Ye Zhen et al. Scientific Reports
- Structural Insights into Separase Architecture and Substrate Recognition through Computational Modelling of Caspase-Like and Death Domains
- (2015) Anja Winter et al. PLoS Computational Biology
- Prodrug Applications for Targeted Cancer Therapy
- (2014) Irene Giang et al. AAPS Journal
- Protease-Activatable Hybrid Nanoprobe for Tumor Imaging
- (2014) Yaping Wang et al. ADVANCED FUNCTIONAL MATERIALS
- Activity-Based Profiling of Proteases
- (2014) Laura E. Sanman et al. Annual Review of Biochemistry
- Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity
- (2014) Robert Løvsletten Smith et al. BIOORGANIC & MEDICINAL CHEMISTRY
- P3 SAR exploration of biphenyl carbamate based Legumain inhibitors
- (2014) Catherine Higgins et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage
- (2014) Lixia Zhao et al. CELL RESEARCH
- Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
- (2014) Zhentao Zhang et al. NATURE MEDICINE
- Proteolysis mediated by cysteine cathepsins and legumain—recent advances and cell biological challenges
- (2014) Klaudia Brix et al. PROTOPLASMA
- Peptide-based MRI contrast agent and near-infrared fluorescent probe for intratumoral legumain detection
- (2013) Yu-Jen Chen et al. BIOMATERIALS
- Acidic extracellular microenvironment and cancer
- (2013) Yasumasa Kato et al. Cancer Cell International
- Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis
- (2013) Yingying Lin et al. CANCER SCIENCE
- Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease
- (2013) Gustavo Basurto-Islas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of legumain as a potential prognostic factor on gastric cancers
- (2013) Na Li et al. MEDICAL ONCOLOGY
- Nuclear Legumain Activity in Colorectal Cancer
- (2013) Mads H. Haugen et al. PLoS One
- Expression of Legumain Correlates with Prognosis and Metastasis in Gastric Carcinoma
- (2013) Pengtao Guo et al. PLoS One
- Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation
- (2013) E. Dall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M
- (2012) Robert Smith et al. BIOCHIMIE
- Microenvironment-mediated resistance to anticancer therapies
- (2012) Oakley C Olson et al. CELL RESEARCH
- Cyclic Peptides Arising by Evolutionary Parallelism via Asparaginyl-Endopeptidase-Mediated Biosynthesis
- (2012) J. S. Mylne et al. PLANT CELL
- Protease-Activated Drug Development
- (2012) Ki Young Choi et al. Theranostics
- Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile
- (2011) Elfriede Dall et al. Acta Crystallographica Section F-Structural Biology and Crystallization Communications
- Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain
- (2011) Jiyoun Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Targeting Cell Surface Alpha(v)beta(3) Integrin Increases Therapeutic Efficacies of a Legumain Protease-Activated Auristatin Prodrug
- (2011) Yuan Liu et al. MOLECULAR PHARMACEUTICS
- Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity
- (2011) Debbie Liao et al. Nanomedicine-Nanotechnology Biology and Medicine
- Albumins and their processing machinery are hijacked for cyclic peptides in sunflower
- (2011) Joshua S Mylne et al. Nature Chemical Biology
- Cystatin E/M suppresses legumain activity and invasion of human melanoma
- (2010) Jon J Briggs et al. BMC CANCER
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- The Legumain Protease-Activated Auristatin Prodrugs Suppress Tumor Growth and Metastasis without Toxicity
- (2010) Krishna Mohan Bajjuri et al. ChemMedChem
- Distinct Protease Requirements for Antigen Presentation In Vitro and In Vivo
- (2010) Stephen P. Matthews et al. JOURNAL OF IMMUNOLOGY
- Development of Near-Infrared Fluorophore (NIRF)-Labeled Activity-Based Probes forin VivoImaging of Legumain
- (2009) Jiyoun Lee et al. ACS Chemical Biology
- A Novel Antitumor Prodrug Platform Designed to Be Cleaved by the Endoprotease Legumain
- (2009) Liron Stern et al. BIOCONJUGATE CHEMISTRY
- Aza-Peptidyl Michael Acceptor and Epoxide Inhibitors—Potent and Selective Inhibitors of Schistosoma mansoni and Ixodes ricinus Legumains (Asparaginyl Endopeptidases)
- (2009) Asli Ovat et al. JOURNAL OF MEDICINAL CHEMISTRY
- Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes
- (2009) Laura E Edgington et al. NATURE MEDICINE
- Recent Trends in Targeted Anticancer Prodrug and Conjugate Design
- (2008) Yashveer Singh et al. CURRENT MEDICINAL CHEMISTRY
- Application of activity-based probes to the study of enzymes involved in cancer progression
- (2008) Margot G Paulick et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Activity-based probes as a tool for functional proteomic analysis of proteases
- (2008) Marko Fonović et al. Expert Review of Proteomics
- Aza-peptidyl Michael Acceptors. A New Class of Potent and Selective Inhibitors of Asparaginyl Endopeptidases (Legumains) from Evolutionarily Diverse Pathogens
- (2008) Marion G. Götz et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search